MicroRNA (miR)-106b~25 cluster regulates bypass of
doxorubicin and γ-radiation induced senescence by downregulation of the
E-cadherin transcriptional activator EP300. We asked whether upregulation of miR-106~25 cluster generates cells with a truly multidrug resistant (MDR) phenotype and whether this is due to upregulation of the
ATP-binding cassette (
ABC) transporter P-glycoprotein. We used minimally transformed mammary epithelial
breast cancer cells (MTMECs) in which the miR-106b~25 cluster was experimentally upregulated by lentiviral transfection or in which hairpins targeting either EP300 or
E-cadherin mRNAs have been expressed with lentiviruses. We find that overexpression of miR-106b~25 cluster led to the generation of MDR MTMECs (resistant to
etoposide,
colchicine and
paclitaxel).
Paclitaxel resistance was also studied after experimental downregulation of EP300 or
E-cadherin. However none of these cells overexpressed
P-glycoprotein or where able to efflux a fluorescent derivative of
paclitaxel, making this phenotype
drug-transporter independent.
Paclitaxel treatment in MTMECs led to an increase in early apoptotic cells (
Annexin V-positive), activation of
caspase-9 and increase in the proportion of cells at the G2/M phase of the cell cycle. However, MTMEC overexpressing miR-106b~25 cluster, or with EP300 or
E-cadherin downregulated, showed less activation of apoptosis,
caspase-9 and
caspase-3/-7 activities. Thus, miR-106b~25 cluster controls transporter-independent MDR by apoptosis evasion via downregulation of EP300.